Comparing two types of therapy for improving arm function after stroke
Comparative Effects of Intensive and Distributed Constraint-induced Movement Therapy on Upper Extremity Function in Stroke Patients
NA · Riphah International University · NCT06459336
This study is testing two different ways of therapy to see which one helps stroke patients improve their arm function better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 45 Years to 65 Years |
| Sex | All |
| Sponsor | Riphah International University (other) |
| Locations | 1 site (Lahore, Punjab Province) |
| Trial ID | NCT06459336 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effects of two different protocols of constraint-induced movement therapy (CIMT) on upper extremity function in stroke patients. Participants will either undergo an intensive CIMT protocol for 6 hours a day over 6 days or a distributed CIMT protocol for 2.25 hours twice a week over 8 weeks, both totaling 36 hours of therapy. The study aims to determine if these two approaches yield similar improvements in motor outcomes for patients recovering from stroke. This research addresses a gap in existing literature regarding the comparative effectiveness of these CIMT protocols.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 40-70 who have experienced a stroke and have specific motor function capabilities.
Not a fit: Patients with severe systemic illnesses, epilepsy, or recent interventions on the upper extremity may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the most effective therapy approach for improving arm function in stroke patients.
How similar studies have performed: While many studies have explored CIMT, this specific comparative approach is novel and has not been directly tested before.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 40-70 years * ischemic or hemorrhagic stroke * Both genders eligible * Gcs score ≥ 13 * Able to extend at least 10° at the fingers * Able to extend at least 20° at the wrist * Patients diagnosed with one side more affected(hemiplegia) * Modified Ashworth scale score ≤2 Exclusion Criteria: * severe, chronic systemic illness * Epilepsy * History of fall past 6 months * Injections of botulinum toxin type A or operations on the UE within 6 months
Where this trial is running
Lahore, Punjab Province
- Hameed Latif Hospital — Lahore, Punjab Province, Pakistan (RECRUITING)
Study contacts
- Principal investigator: Wajiha Shahid, Phd — Riphah International University
- Study coordinator: Imran Amjad, Phd
- Email: imran.amjad@riphah.edu.pk
- Phone: 03324390125
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stroke, upper extremity function